Curaleaf (OTCMKTS:CURLF) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Curaleaf (OTCMKTS:CURLF) released its quarterly earnings data on Monday. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.09, Zacks reports. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%.

Curaleaf Stock Down 9.9 %

Curaleaf stock opened at $1.18 on Tuesday. The stock has a market cap of $779.54 million, a price-to-earnings ratio of -4.07 and a beta of 0.60. The company has a current ratio of 1.11, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. The company’s 50-day moving average price is $1.45 and its two-hundred day moving average price is $2.20. Curaleaf has a 52 week low of $0.88 and a 52 week high of $6.40.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Roth Capital upgraded shares of Curaleaf to a “strong-buy” rating in a research note on Sunday, November 10th. Cormark downgraded shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.